Showing results (341-350 of 376) with videos related to

Sort By:
Pageof 38
Blood|January 29, 2021
Modeling and targeting of erythroleukemia by hematopoietic genome editingIlaria Iacobucci, Chunxu Qu, Elena Varotto, et al.
Journal for Immunotherapy of Cancer|October 8, 2024
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myelomaJan H Frenking, Xiang Zhou, Vivien Wagner, et al.
JACC. Advances|September 16, 2024
Coronary Artery Calcium for Risk Stratification Among Persons With Very High HDL CholesterolAlexander C Razavi, Anurag Mehta, Nathan D Wong, et al.
Blood Advances|April 23, 2025
Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myelomaJan Hendrik Frenking, Xiang Zhou, Kai Rejeski, et al.
Nutrition Reviews|September 24, 2017
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelArrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Communications|June 30, 2022
Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational statePeter G Miller, Murugappan Sathappa, Jamie A Moroco, et al.
Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.
American Journal of Preventive Cardiology|September 22, 2025
Interleukin-6 is associated with high-risk plaque on coronary computed tomography angiography in asymptomatic womenNishant Vatsa, Raymundo A Quintana, Phillipp Knebel Doeberitz, et al.
Pageof 38